Hematology NewsFDA approves first 2 gene-editing therapies for sickle cellDecember 8, 2023Gene TherapyBleeding Disorders
Oncology PracticeTrop-2 drug conjugate may trump chemo in HR+, HER2- breast cancerDecember 8, 2023Breast CancerPatient & Survivor Care
Oncology PracticeCan younger postmenopausal women with low-risk BC skip radiation?December 8, 2023Breast CancerPatient & Survivor Care
Oncology PracticeSleep problems exact high toll in women with breast cancerDecember 8, 2023Breast CancerPatient & Survivor Care
Oncology PracticeWhen to skip regional nodal radiation in breast cancerDecember 7, 2023Breast CancerPatient & Survivor Care
Oncology PracticeWhat will help ease the financial toll of breast cancer?December 7, 2023Breast CancerPractice ManagementPatient & Survivor Care
Oncology PracticeHER2+ Combo Shows Promise in Breast Cancer Brain MetsDecember 7, 2023Breast CancerPatient & Survivor Care
Oncology PracticeCompelling case for skipping RT in some early breast cancersDecember 7, 2023Breast CancerPatient & Survivor Care
Hematology NewsFDA greenlights iptacopan to treat paroxysmal nocturnal hemoglobinuriaDecember 6, 2023Bleeding Disorders
Oncology PracticeAre you sure your patient is alive?December 6, 2023Business of MedicinePractice Management
Hematology NewsHematology is in the Brodsky family’s bloodDecember 6, 2023Mixed TopicsCMLBleeding DisordersTransplantThrombosisAnemiaMyelodysplastic Syndrome
Oncology PracticeHow the microbiome influences the success of cancer therapyDecember 5, 2023ImmunotherapyImmuno-oncologyPatient & Survivor Care
Oncology PracticeEven with insurance, cancer out-of-pocket costs can be punishingDecember 5, 2023Practice Management
Oncology PracticeHow to address chemo-related amenorrhea in early breast cancer to help improve quality of lifeDecember 4, 2023Breast CancerPatient & Survivor Care
Hematology NewsASH 2023: Equity, Sickle Cell, and Real-Life OutcomesDecember 4, 2023Mixed TopicsBleeding DisordersAMLThrombosisTransplantMultiple MyelomaMyelodysplastic Syndrome
